Machine learning-based diagnostic prediction of IgA nephropathy: model development and validation study.
Source check: Source checked. Not independent scientific confirmation.
Finding: original PDF verifies biopsy-reference diagnosis prediction with temporal validation in 1,268 patients; reported held-out metrics support a specific diagnostic result, not clinical deployment. AI role: XGBoost, LightGBM, random forest, neural networks, 1D-CNN and logistic regression. The article appeared in Scientific Reports.
Technology: XGBoost, LightGBM, random forest, neural networks, 1D-CNN and logistic regression
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- XGBoost, LightGBM, random forest, neural networks, 1D-CNN and logistic regression
- Test and result
- original PDF verifies biopsy-reference diagnosis prediction with temporal validation in 1,268 patients; reported held-out metrics support a specific diagnostic result, not clinical deployment.
- Limitation / still unknown
- The result is limited to the described dataset, cohort, experimental system, or validation design; generalization beyond that scope and downstream real-world benefit are not established. Author affiliation was not stated in the reviewed abstract or metadata.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://europepmc.org/article/MED/38816457 · https://www.nature.com/articles/s41598-024-63339-7.pdf · https://pubmed.ncbi.nlm.nih.gov/38816457/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.